Guerbet SA (EPA:GBT)

Market Cap	111.39M -66.0%
Revenue (ttm)	799.30M -6.1%
Net Income	-112.70M
EPS	n/a
Shares Out	12.60M
PE Ratio	n/a
Forward PE	9.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,784
Average Volume	14,358
Open	9.00
Previous Close	9.27
Day's Range	8.70 - 9.01
52-Week Range	8.70 - 27.85
Beta	0.72
RSI	10.73
Earnings Date	Mar 11, 2026

About Guerbet

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine; Elucirem, a macrocyclic gadolinium-based contrast agent; and Artirem, a gadoteric acid that acts a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1926
• Employees: 2,905
• Stock Exchange: Euronext Paris
• Ticker Symbol: GBT